News
BBLG
0.4960
+0.98%
0.0048
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 3d ago
Weekly Report: what happened at BBLG last week (0914-0918)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/17 12:05
Weekly Report: what happened at BBLG last week (0907-0911)?
Weekly Report · 09/14 10:07
Weekly Report: what happened at BBLG last week (0831-0904)?
Weekly Report · 09/07 10:01
Weekly Report: what happened at BBLG last week (0824-0828)?
Weekly Report · 08/31 10:07
Weekly Report: what happened at BBLG last week (0817-0821)?
Weekly Report · 08/24 10:08
Weekly Report: what happened at BBLG last week (0810-0814)?
Weekly Report · 08/17 10:09
Bone Biologics announces extended shelf life for rhNELL-1 protein
TipRanks · 08/17 09:42
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 08/12 21:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 08/12 17:05
Bone Biologics Extends RhNELL-1 Shelf Life To 32 Months, Strengthening Study Readiness; Stock Down
NASDAQ · 08/12 13:45
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 08/12 12:06
Weekly Report: what happened at BBLG last week (0803-0807)?
Weekly Report · 08/10 10:04
Weekly Report: what happened at BBLG last week (0727-0731)?
Weekly Report · 08/03 10:04
Weekly Report: what happened at BBLG last week (0720-0724)?
Weekly Report · 07/27 10:08
Weekly Report: what happened at BBLG last week (0713-0717)?
Weekly Report · 07/20 10:05
Bone Biologics Files Prospectus To Offer Up To 6.46M Shares Of Common Stock By Selling Stockholders
Benzinga · 07/17 21:22
Bone Biologics files to sell 6.46M shares of common stock for holders
TipRanks · 07/17 21:20
Weekly Report: what happened at BBLG last week (0706-0710)?
Weekly Report · 07/13 10:06
More
Webull provides a variety of real-time BBLG stock news. You can receive the latest news about Bone Biologics Corp through multiple platforms. This information may help you make smarter investment decisions.
About BBLG
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.